373 related articles for article (PubMed ID: 30588882)
41. Effect of mPEG-PLGA on Drug Crystallinity and Release of Long-Acting Injection Microspheres: In Vitro and In Vivo Perspectives.
Xing D; Tang L; Yang H; Yan M; Yuan P; Wu Y; Zhang Y; Yin T; Wang Y; Gou J; Tang X; He H
Pharm Res; 2024 Jun; 41(6):1271-1284. PubMed ID: 38839720
[TBL] [Abstract][Full Text] [Related]
42. The influence of covalently linked and free polyethylene glycol on the structural and release properties of rhBMP-2 loaded microspheres.
Lochmann A; Nitzsche H; von Einem S; Schwarz E; Mäder K
J Control Release; 2010 Oct; 147(1):92-100. PubMed ID: 20603166
[TBL] [Abstract][Full Text] [Related]
43. Preparation, characterization, and pharmacodynamics of exenatide-loaded poly(DL-lactic-co-glycolic acid) microspheres.
Liu B; Dong Q; Wang M; Shi L; Wu Y; Yu X; Shi Y; Shan Y; Jiang C; Zhang X; Gu T; Chen Y; Kong W
Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1474-9. PubMed ID: 21048339
[TBL] [Abstract][Full Text] [Related]
44. Preparation of poly(lactide-co-glycolide) microspheres and evaluation of pharmacokinetics and tissue distribution of BDMC-PLGA-MS in rats.
Li G; Yao L; Li J; Qin X; Qiu Z; Chen W
Asian J Pharm Sci; 2018 Jan; 13(1):82-90. PubMed ID: 32104381
[TBL] [Abstract][Full Text] [Related]
45. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres.
Shi L; Caulfield MJ; Chern RT; Wilson RA; Sanyal G; Volkin DB
J Pharm Sci; 2002 Apr; 91(4):1019-35. PubMed ID: 11948541
[TBL] [Abstract][Full Text] [Related]
46. DEVELOPMENT OF OLANZAPINE LOADED PNA MICROGELS FOR DEPOT DRUG DELIVERY IN TREATMENT OF SCHIZOPHRENIA: IN VITRO AN IN VIVO RELEASE PROFILE.
Pervaiz F; Ahmad M; Hussain T; Idrees A; Yaqoob A; Abbas K
Acta Pol Pharm; 2016; 73(1):175-81. PubMed ID: 27008812
[TBL] [Abstract][Full Text] [Related]
47. Development of lovastatin-loaded poly(lactic acid) microspheres for sustained oral delivery: in vitro and ex vivo evaluation.
Guan Q; Chen W; Hu X
Drug Des Devel Ther; 2015; 9():791-8. PubMed ID: 25709403
[TBL] [Abstract][Full Text] [Related]
48. Studies on the preparation, characterization and pharmacological evaluation of tolterodine PLGA microspheres.
Sun F; Sui C; Teng L; Liu X; Teng L; Meng Q; Li Y
Int J Pharm; 2010 Sep; 397(1-2):44-9. PubMed ID: 20600717
[TBL] [Abstract][Full Text] [Related]
49. Ondansetron-loaded biodegradable microspheres as a nasal sustained delivery system: in vitro/in vivo studies.
Gungor S; Okyar A; Erturk-Toker S; Baktir G; Ozsoy Y
Pharm Dev Technol; 2010 Jun; 15(3):258-65. PubMed ID: 22716466
[TBL] [Abstract][Full Text] [Related]
50. Design of Controlled Release PLGA Microspheres for Hydrophobic Fenretinide.
Zhang Y; Wischke C; Mittal S; Mitra A; Schwendeman SP
Mol Pharm; 2016 Aug; 13(8):2622-30. PubMed ID: 27144450
[TBL] [Abstract][Full Text] [Related]
51. Preparation and properties of monodispersed rifampicin-loaded poly(lactide-co-glycolide) microspheres.
Ito F; Makino K
Colloids Surf B Biointerfaces; 2004 Nov; 39(1-2):17-21. PubMed ID: 15542335
[TBL] [Abstract][Full Text] [Related]
52. Preparation, Characterization and Evaluation of Drug Release Properties of Simvastatin-loaded PLGA Microspheres.
Masaeli R; S Jafarzadeh Kashi T; Dinarvand R; Tahriri M; Rakhshan V; Esfandyari-Manesh M
Iran J Pharm Res; 2016; 15(Suppl):205-211. PubMed ID: 28228818
[TBL] [Abstract][Full Text] [Related]
53. A novel long-acting biodegradable depot formulation of anastrozole for breast cancer therapy.
Shavi GV; Nayak UY; Reddy MS; Ginjupalli K; Deshpande PB; Averineni RK; Udupa N; Sadhu SS; Danilenkoff C; Raghavendra R
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():535-544. PubMed ID: 28415496
[TBL] [Abstract][Full Text] [Related]
54. Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery.
Sheshala R; Peh KK; Darwis Y
Drug Dev Ind Pharm; 2009 Nov; 35(11):1364-74. PubMed ID: 19832637
[TBL] [Abstract][Full Text] [Related]
55. Development of near zero-order release PLGA-based microspheres of a novel antipsychotic.
Zhao J; Wang L; Fan C; Yu K; Liu X; Zhao X; Wang D; Liu W; Su Z; Sun F; Li Y
Int J Pharm; 2017 Jan; 516(1-2):32-38. PubMed ID: 27825865
[TBL] [Abstract][Full Text] [Related]
56. Injectable PLGA Adefovir microspheres; the way for long term therapy of chronic hepatitis-B.
Ayoub MM; Elantouny NG; El-Nahas HM; Ghazy FES
Eur J Pharm Sci; 2018 Jun; 118():24-31. PubMed ID: 29555501
[TBL] [Abstract][Full Text] [Related]
57. Formulation and in vitro/in vivo evaluation of terbutaline sulphate incorporated in PLGA (25/75) and L-PLA microspheres.
Selek H; Sahin S; Ercan MT; Sargon M; Hincal AA; Kas HS
J Microencapsul; 2003; 20(2):261-71. PubMed ID: 12554379
[TBL] [Abstract][Full Text] [Related]
58. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
[TBL] [Abstract][Full Text] [Related]
59. A poly(D,L-lactide-co-glycolide) microsphere depot system for delivery of haloperidol.
Cheng YH; Illum L; Davis SS
J Control Release; 1998 Nov; 55(2-3):203-12. PubMed ID: 9795060
[TBL] [Abstract][Full Text] [Related]
60. Improved corneal bioavailability of ofloxacin: biodegradable microsphere-loaded ion-activated in situ gel delivery system.
Sayed EG; Hussein AK; Khaled KA; Ahmed OA
Drug Des Devel Ther; 2015; 9():1427-35. PubMed ID: 25792803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
